Bilateral masculine mastoplasia associated with imatinib mesylate: A case report and literature review

Keywords

masculine mastoplasia / imatinib mesylate / side effect

References

[1] BaccaraniM., SaglioG., GoldmanJ., et al.. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood, 2006, 108(6): 1809-1820

[2] AntarjianH., SawyersC., HochhausA., et al.. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med, 2002, 346(9): 645-652

[3] Gambacorti-PasseriniC., TornaghiL., CavagniniF., et al.. Gynaecomastia in men with chronic myeloid leukaemia after imatinib. Lancet, 2003, 361(9373): 1954-1956

[4] KimH., ChangH.M., RyuM.H., et al.. Concurrent male gynecomastia and testicular hydrocele after imatinib mesylate treatment of a gastrointestinal stromal tumor. J Korean Med Sci, 2005, 20(3): 512-515

[5] CakanN., KamatD.. Gynecomastia: evaluation and treatment recommendations for primary care providers. Clin Pediatr (Phila), 2007, 46(6): 487-490

[6] EckmanA., DobsA.. Drug-induced gynecomastia. Expert Opin Drug Saf, 2008, 7(6): 691-702

[7] BemboS.A., CarlsonH.E.. Gynecomastia: its features, and when and how to treat it. Cleve Clin J Med, 2004, 71(6): 511-517

[8] AscianiS., MarianiS., ArizziM., et al.. Expression of platelet-derived growth factor-A (PDGF-A), PDGF-B, and PDGF receptor-alpha and -beta during human testicular development and disease. J Clin Endocrinol Metab, 2002, 87(5): 2310-2319

[9] GoldmanR.D.. Drug-induced gynecomastia in children and adolescents. Can Fam Physician, 2010, 56(4): 344-345